Connect Biopharma (CNTB) vs Hyperion DeFi (HYPD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Connect Biopharma (CNTB) has outperformed Hyperion DeFi (HYPD) over the past year, losing 46.9% versus a loss of 61.6%. Over five years, CNTB leads with a -94.5% price change compared with -99.2% for HYPD. Connect Biopharma is the larger company by market cap ($56.1 million vs $50.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNTB | HYPD |
|---|---|---|
| Share price | $0.8915 | $3.31 |
| Market cap | $56.14M | $50.26M |
| 1-day change | -5.63% | -7.91% |
| YTD return | -66.50% | +0.84% |
| 1-year return | -46.93% | -61.60% |
| 5-year return | -94.50% | -99.15% |
| EPS (TTM) | $-1.19 | $-6.46 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.82 | $9.50 |
| 52-week low | $0.85 | $2.34 |
| Distance from 52-week high | -76.66% | -65.20% |
| Average volume | 3.83M | 445.34K |
| Shares outstanding | 62.97M | 15.20M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CNTB has outperformed HYPD by 14.7 percentage points over the past year.
CNTB vs HYPD FAQ
Which is bigger, Connect Biopharma or Hyperion DeFi?
Connect Biopharma (CNTB) is larger, with a market capitalization of $56.14M compared with $50.26M for Hyperion DeFi (HYPD).
Which stock has performed better over the past year, CNTB or HYPD?
CNTB returned -46.93% over the past 12 months, compared with -61.60% for HYPD (price return, excluding dividends). Past performance does not predict future results.
Are Connect Biopharma and Hyperion DeFi in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.